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Abstract
Objective: To correlate lipid metabolism and autonomic dysfunction with anxious-depressive spectrum and eating
disorders. To propose the lipid index (LI) as a new possible biomarker.
Methods: 95 patients and 60 controls were enrolled from the University Psychiatry Unit of Catania and from
general practitioners (GPs). The patients were divided into four pathological groups: Anxiety, Depression, Anxious-
Depressive Disorder and Eating Disorders [Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text
Revision (DSM-IV-TR) official/appendix criteria]. The levels of the cholesterol, triglycerides and apolipoproteins A and
B were determined. The LI, for each subject, was obtained through a mathematical operation on the values of the
cholesterol and triglycerides levels compared with the maximum cut-off of the general population. The autonomic
functioning was tested with Ewing battery tests. Particularly, the correlation between heart rate variability (HRV)
and lipid metabolism has been investigated.
Results: Pathological and control groups, compared among each other, presented some peculiarities in the lipid
metabolism and the autonomic dysfunction scores. In addition, a statistically significant correlation has been found
between HRV and lipid metabolism.
Conclusions: Lipid metabolism and autonomic functioning seem to be related to the discussed psychiatric
disorders. LI, in addition, could represent a new possible biomarker to be considered.
Keywords: depression, anxiety, anxious-depressive disorder, eating disorders, lipid metabolism, autonomic nervous
system functioning, lipid index
Background
The dysfunctions of lipid metabolism and autonomic
nervous system have been found to be linked with
anxious-depressive spectrum and eating disorders
[1-19], but no definitive conclusions has yet been
reached.
The aim of this work is to correlate the levels of cho-
lesterol, triglycerides, apolipoproteins A-B, LI and auto-
nomic dysfunction to depression, anxiety, anxious-
depressive disorder and eating disorders. In addition, the
correlation between HRV and lipid metabolism has been
tested.
Methods
95 patients (32 men and 63 women, mean age 46.0 SD ±
15.5) and 60 controls (36 men and 24 women, mean age
50.5 SD ± 10.8) were enrolled from the University Psy-
chiatry Unit of Catania and from GPs. The demographic
characteristics of the pathological and control groups are
reported in Table 1.
The local ethics committee approved this study (n.
321 register of trials), and all participants signed an
informed consent.
Subjects with familial dyslipidemia, heart disease and
psychotic disorders were excluded from the study.
Four pathological groups were created: Anxiety, Depres-
sion, Anxious-Depressive Disorder and Eating Disorders
(ED) (Anorexia, Bulimia, Binge Eating Disorder). The
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DSM-IV-TR (official/appendix criteria)[20].
Figure 1 shows the distribution of the pathological
groups.
The autonomic nervous system (ANS) functioning was
evaluated with the Ewing battery of tests through an
electrocardiograph and a sphygmomanometer; particu-
larly: Deep Breathing, Lying-to-Standing, Valsalva Man-
oeuvre and Sustained Handgrip tests [21,22]. Scores
from 1 (mild) to 5 (severe) were considered parameters
of autonomic dysfunction, passing through intermediate
values of severity [23].
Particularly, the correlation between HRV (time-domain
method) and lipid metabolism has been investigated.
Cholesterol, triglycerides and apolipoproteins A and B
were analyzed through fasting blood samples. All the
analyses were repeated three times.
Normal fasting rates of triglycerides range from 50 to
160 mg/dl; normal fasting rates of cholesterol range
from 100 to 200 mg/dl [24].
All the subjects’ rates of cholesterol and triglycerides
were compared to the maximum cut-off of the general
population (subject cholesterolemia/200; subject trigli-
ceridemia/160) thus creating two ratios: cholesterol
index (CI) and triglycerides index (TI).
Through the operation CI - TI the LI was obtained. A
positive index number means that the cholesterol pro-
duction is prevalent, while a negative one indicates a
prevalent triglycerides production.
A value of + 0,15 or - 0,15 could be taken as 0, since
it could be considered an irrelevant nutritional variation.
Data analysis
The Statistical Package for Social Sciences (SPSS, 2000)
was used. T-test and Z test were used. The association
between categorical descriptive variables was tested
through paired-samples t-test.
Mann-Whitney test was used to compare the results
regarding the Ewing score. Pearson correlation has been
performed to find possible correlations between HRV
and lipid metabolism. The p values were then obtained





The anxious-depressive disorder group, compared to all
the other groups (anxiety: t = 2,27, p < 0,025; depression:
t = 3,42, p < 0,005; ED: t = 2,94, p < 0,005), and to the
Table 1 Demographic characteristics of the sample
Group N % Age
Depression 39 50 ± 14.8
M 9 23% 49.8 ± 14.3
F 30 77% 50 ± 14.0
Anxiety 28 48.0 ± 17.7
M 16 57% 48.6 ± 16.2
F 12 43% 47.1 ± 20.2
Anxious-depressive disorder 13 46.6 ± 13.8
M 6 54% 52.8 ± 10.6
F 7 46% 41.4 ± 14.7
Eating Disorders 15 31.3 ± 7.06
M 1 7% 24
F 14 93% 31.8 ± 7.02
Controls 60 50.5 ± 10.8
M 36 60% 50.6 ± 9.9
F 24 40% 50.3 ± 12.3
Legend: The table shows data regarding the male (M) and female (F)
distribution within every group, in number (N) and percentage (%). In
addition, age is reported, referring to the whole group and to the gender
[mean age and standard deviation (±)].
Figure 1 (Distribution of pathological groups)-Legend: the percentages of the pathological groups within the sample are shown.
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cholesterol.
With regards to the other groups, their cholesterol
levels were higher compared to the control group, but
there was not a statistically significant difference
between the pathological groups compared among each
other.
Triglycerides
The anxiety and anxious-depressive disorder groups,
compared among each other, did not present a statisti-
cally significant difference in the triglycerides levels, but
they both presented significantly higher triglycerides
levels compared to all the other groups and to the con-
trol group (the anxiety group versus: depression: t = 4,5,
p < 0,005; ED: t = 6,31, p < 0,05; control group: t =
5,41, p < 0,005); (the anxious-depressive disorder group
versus: depression: t = 6,7, p < 0,005; ED t = 10,7, p <
0,005; control group: t = 2,91, p < 0,005).
The depression group presented lower triglycerides
levels, when compared to anxiety, anxious-depressive dis-
order and control groups (Z = 4,46, p < 0,001); higher tri-
glycerides levels, when compared to the eating disorders
group (t = 3,36, p < 0,005), which presented lower trigly-
cerides levels than in all the pathological and control
groups (t = 8,31, p < 0,005).
LI
The eating disorders group presented the highest LI
among the pathological and control groups (depression:
t = 4,75, p < 0,005; anxiety: t = 5,87, p < 0,005; anxious-
depressive disorders: t = 14, p < 0,005; control group: t =
12,5, p < 0,005). The LI, among the anxiety and anxious-
depressive disorder groups, did not present a statistically
significant difference, but it was significantly lower than
that of the control group and of the other pathological
groups (t = 2, p < 0,05). In terms of average, the anxious-
depressive disorder group presented the lowest LI of the
w h o l es a m p l eo ft h es t u d y .
The depression group presented, therefore, a higher LI
than did the anxiety (t = 3.5, p < 0.005) and anxious-
depressive disorder groups (t = 9,25, p < 0,005), but did
not present a statistically significant difference compared
to the control group.
Apolipoproteins A and B
The general population maximum cut-off was not
exceeded either in the pathological groups or in the
control one. Nevertheless, the anxious-depressive disor-
der group presented higher levels of Apolipoproteins A,
compared to the other groups and to the control group.
This same pattern was observed for Apolipoproteins B,
only in the anxiety group.
For more details about the results regarding lipid
metabolism, see Table 2.
Autonomic Nervous System Functioning
Among the pathological groups, the most represented
autonomic dysfunctions were at a mild-mild/moderate
level (see Figure 2). Among the control group, 51.7% did
not present autonomic dysfunctions, 33.3% presented
mild dysautonomia and 15.0% presented mild/moderate
dysautonomia. In contrast to the pathological groups, the
control group did not present other, more severe, dysau-
tonomia levels. All the pathological groups presented a
statistically significant difference compared to the control
group considering mild/moderate dysautonomia (Mann
Table 2 Demographic data and serum lipid levels in pathological and control groups
Group Age TC TG LI ApoA ApoB
Depression 50 ± 14.8 202.4 ± 49.6 88.1 ± 36.2 0.46 ± 0.2 155.7 ± 39.1 125.1 ± 49.7
M 49.8 ± 14.3 171.2 ± 40.5 93.7 ± 34.0 0.27 ± 0.1 161.3 ± 36.6 98.7 ± 11.9
F 50 ± 14.0 211.0 ± 48.8 86.4 ± 37.3 0.52 ± 0.2 154.1 ± 40.3 133.0 ± 54.0
Anxiety 48.0 ± 17.7 190.7 ± 47.2 181.2 ± 81.5 -0.18 ± 0.4 161.9 ± 56.9 169.9 ± 32.9
M 48.6 ± 16.2 201.0 ± 34.2 195.3 ± 93.3 -0.22 ± 0.5 154.5 ± 56.4 172.8 ± 28.8
F 47.1 ± 20.2 177 ± 59.3 162.5 ± 61.3 -0.13 ± 0.24 167.5 ± 59.2 166.1 ± 38.6
Anxious-depressive disorder 46.6 ± 13.8 160.9 ± 28.1 143.7 ± 19.5 -0.09 ± 0.10 189.3 ± 41.1 125.9 ± 42.2
M 52.8 ± 10.6 148.3 ± 15.6 134 22.8 -0.09 ± 0.12 170.8 ± 54.8 114.1 ± 43.1
F 41.4 ± 14.7 171.7 ± 33.0 152.1 ± 12.3 -0.10 ± 0.08 205.1 ± 15.9 136 ± 41.9
Eating Disorders 31.3 ± 7.06 197 ± 31.48 53.5 ± 25.6 0.65 ± 0.1 130.9 ± 44.5 156.5 ± 35.8
M 24 201 49 0.07 106 170
F 31.8 ± 7.02 197 ± 32.65 53.8 ± 26.6 0.65 ± 0.1 132.7 ± 45.7 155.5 ± 36.9
Controls 50.5 ± 10.8 177.9 ± 19.9 119 ± 27.9 0.15 ± 0.2 135.7 ± 42.2 145.8 ± 33.5
M 50.6 ± 9.9 177.6 ± 18.3 123.6 ± 29.2 0.12 ± 0.2 146.4 ± 44.9 140.8 ± 36.0
F 50.3 ± 12.3 178.0 ± 12.3 112 ± 24.8 0.19 ± 0.1 119.7 ± 32.4 153.4 ± 28.5
Legend: Data regarding age and lipid blood levels of every group are reported [as mean and standard deviation(±)], referring to the entire group and to the
gender. M = male; F = female; TC = total cholesterol; TG = triglycerides; LI = lipid index; ApoA and ApoB = apolipoproteins A and B.
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average, the highest Ewing score was in the anxious-
depressive disorder group. For more details, see Table 3.
With regards, in particular, to HRV, there was not a
statistically significant difference among the pathological
groups (p > 0,1). When compared to the control group,
only the depression and anxiety groups presented a sta-
tistically significant difference (p = 0,05). The anxious-
depressive group, in terms of mean value, is the group
with the lowest HRV of the whole sample (33,1 ± 10,2).
Considering the whole sample, the correlation between
ANS and lipid metabolism has been investigated, refer-
ring in particular to HRV, with highly statistically signif-
icant results (p < 0,01). HRV and LI presented a positive
correlation: the anxious-depressive disorder group, in
fact, presented the lowest LI (showing to be the group
with the most severe triglycerides hyperproduction) and
the lowest HRV. Correspondingly, this group was the
one with the highest average of Ewing score. HRV has
been found to be inversely related to the triglycerides
levels and positively related to the cholesterol levels;
these results confirmed the HRV-LI correlation.
Figure 2 (Ewing score of patients)-Legend: the distribution of the different levels of the autonomic dysfunctions within the whole
pathological sample is shown in percentage.
Table 3 Sample’s Ewing score
Group Ewing score
Depression 1.3 ± 0.8
M 1.4 ± 1.3
F 1.3 ± 0.7
Anxiety 1.3 ± 0.9
M 1.1 ± 0.8
F 1.5 ± 0.9
Anxious-depressive disorder 2 ± 0.9
M 2.1 ± 0.9
F 1.8 ± 0.8
Eating Disorders 1.5 ± 0.6
M2
F 1.5 ± 0.6
Controls 0.6 ± 0.7
M 0.7 ± 0.7
F 0.4 ± 0.5
Legend: The Ewing score of each group is reported [mean and standard
deviation(±)], referring to the entire group and to the gender. M = male; F =
female.
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HRV. The opposite has been found for Apolipoproteins
B. For more details, see Table 4.
Conclusions
Lipid metabolism and autonomic functioning seem to be
related to the discussed psychiatric disorders.
In a context of enhancing knowledge, the lipid index
could represent another biomarker to be taken into
consideration.
Our findings are far from being definitive, also consid-
ering the small sample size and some disparities in male
and female distribution. Further studies are necessary.
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